Nicotine Tob Res. 2021 Aug 18;23(9):1459-1467. doi: 10.1093/ntr/ntab041.
Prevalence and Distribution of Electronic Cigarette Use Before and During Pregnancy Among Women in 38 States of the United States.
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco
Buyun Liu, Yang Du, Yuxiao Wu, Yangbo Sun, Mark K Santillan, Donna A Santillan, Wei Bao
Affiliations
Affiliations
- Department of Epidemiology, College of Public Health, University of Iowa, Iowa City, IA, USA.
- Department of Obstetrics & Gynecology, University of Iowa, Iowa City, IA, USA.
PMID: 33693836
PMCID: PMC8517965 DOI: 10.1093/ntr/ntab041
Abstract
INTRODUCTION: To examine the prevalence and the changing pattern of e-cigarette use from preconception to pregnancy.
AIMS AND METHODS: This is a cross-sectional study using data from the multi-site Pregnancy Risk Assessment Monitoring System in the United States, 2016-2017. All participating mothers with information on e-cigarette use before and during pregnancy were included. Self-reported information about e-cigarette use were assessed using questionnaires. Weighted prevalences of e-cigarette use before and during pregnancy were calculated. Multivariable logistic regressions were used to examine the association between various demographic characteristics and e-cigarette use before or during pregnancy.
RESULTS: This study included 69 508 pregnant women from 38 states in the United States. The weighted prevalence of e-cigarette use before pregnancy and during the last 3 months of pregnancy was 3.6% (95% confidence interval [CI] 3.4%-3.9%) and 1.1% (0.9%-1.2%), respectively. The prevalence varied across states, ranging from 1.3% to 8.3% for e-cigarette use before pregnancy and from 0.1% to 3.4% for e-cigarette use during the last 3 months of pregnancy. Among women who used e-cigarettes before pregnancy, 24.4% (21.7%-27.1%) continued to use e-cigarettes during pregnancy. Among women who used e-cigarettes during pregnancy, 62.3% (56.5%-68.0%) were dual users. In multivariable analyses, cigarette smoking was most strongly associated with e-cigarette use. The adjusted odds ratio comparing smokers with nonsmokers before pregnancy was 11.10 (95% CI 9.34-13.20) for e-cigarette use before pregnancy and 6.72 (95% CI 4.38-10.31) for e-cigarette use during pregnancy.
CONCLUSIONS: Using data from 38 states in the United States, we showed geographical variations in the prevalence of e-cigarette use before and during pregnancy. Among women who used e-cigarettes before pregnancy, a quarter of them continued to use e-cigarettes during pregnancy. Conventional cigarette use is a strong risk factor for e-cigarette use before and during pregnancy. The prevalence of e-cigarette use needs to be monitored continuously.
IMPLICATIONS: This study provides important information to understand the status and changing patterns of e-cigarette use in pregnant women in the United States. Among pregnant women in 38 states in the United States, 3.6% of them used e-cigarettes during the 3 months before pregnancy and 1.1% used them during the last 3 months of pregnancy. The prevalence varied across states. A quarter of women who used e-cigarettes before pregnancy continued to use e-cigarettes during pregnancy. Cigarette smoking is the strongest predictor of e-cigarette use. Future research about health effects of e-cigarette use during pregnancy is in urgent need.
© The Author(s) 2021. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. All rights reserved.For permissions, please e-mail: [email protected].
References
- MMWR Morb Mortal Wkly Rep. 2019 Mar 01;68(8):189-194 - PubMed
- Am J Public Health. 2018 Oct;108(10):1305-1313 - PubMed
- Transl Res. 2019 May;207:70-82 - PubMed
- Int J Environ Res Public Health. 2019 Dec 14;16(24): - PubMed
- Matern Child Health J. 2017 Aug;21(8):1655-1661 - PubMed
- J Okla State Med Assoc. 2018 Oct;111(8):812-816 - PubMed
- Public Health Rep. 2006 Jan-Feb;121(1):74-83 - PubMed
- Am J Respir Crit Care Med. 2016 Mar 1;193(5):486-94 - PubMed
- Addiction. 2014 Nov;109(11):1801-10 - PubMed
- Prev Med. 2020 May;134:106041 - PubMed
- NCHS Data Brief. 2018 Feb;(305):1-8 - PubMed
- Ir J Med Sci. 2017 Nov;186(4):971-979 - PubMed
- Int J Environ Res Public Health. 2017 Oct 11;14(10): - PubMed
- Lancet Respir Med. 2019 Nov;7(11):985-992 - PubMed
- Tob Induc Dis. 2019 May 21;17:44 - PubMed
- J Womens Health (Larchmt). 2020 Jun;29(6):780-788 - PubMed
- Chem Res Toxicol. 2018 Jul 16;31(7):601-611 - PubMed
- JAMA Pediatr. 2019 Jun 1;173(6):600-602 - PubMed
- Health Educ Res. 2017 Feb 1;32(1):22-32 - PubMed
- Nicotine Tob Res. 2017 May 1;19(5):585-590 - PubMed
- Pediatrics. 2020 Mar;145(3): - PubMed
- Obstet Gynecol Surv. 2018 Sep;73(9):544-549 - PubMed
- BMJ. 2018 Jan 17;360:j5543 - PubMed
- Nurs Res. 2016 Sep-Oct;65(5):408-14 - PubMed
- J Addict Med. 2015 Jul-Aug;9(4):266-72 - PubMed
- Tob Control. 2021 Mar;30(2):221-226 - PubMed
- N Engl J Med. 2019 Feb 14;380(7):629-637 - PubMed
MeSH terms
Publication Types
Grant support